IP Library Granted Patent US 8,632,824
Granted Patent B2
US 8,632,824 · App. 11/734,449 · Granted Jan 21, 2014

Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,632,824
App. No.
11/734,449
Granted
Jan 21, 2014
Kind
B2
Abstract

This invention relates to a process by which an extract comprising integral thylakoids is obtained. The resulting extract is a potent dynamic antioxidant useful as a ROS (reactive oxygen species) scavenger. This extract is intended to be used for the treatment or prevention of diseases involving the generation of ROS, such as inflammatory diseases or cancer. This extract also finds a use as a solar screen because of its capacity to capture UV radiations and to dissipate the solar energy into heat.

Claims (25)

1. An extract from a photosynthetic organism obtainable by a method comprising:

(a) providing a suspension of photosynthetic organism constituents that contain thylakoids;

(b) disrupting the constituents while recovering thylakoids under light conditions which minimize light flux, in a medium comprising sugar or sugar alcohol and having a pH above 2 and below 10, the medium being added in a volume calculated upon the following equation:

(Volume of medium+organism constituents water content)/(Organism constituents dry weight)>10

 to obtain a composition consisting essentially of thylakoids, cell debris/membranes and a liquid phase;

(c) separating and isolating an extract from the cell debris/membranes and the liquid phase, wherein the separated and isolated extract consists essentially of pure stabilized integral thylakoids, the thylakoids comprising organized photosynthetic pigments in their fundamental state; and

(d) eliminating any electron donor from the extract.

2. The extract according to claim 1 , wherein the equation is:

(Volume of medium+organism constituents water content)/(Organism constituents dry weight)=25−150.

3. The extract according to claim 1 , wherein the pH is between 5 and 8.

4. The extract according to claim 1 , wherein the pH is between 6 and 7.5.

5. The extract of claim 1 , wherein said organism is a plant.

6. The extract according to claim 5 , wherein the suspension of step (a) is obtained by mechanically dispersing plant constituents or tissues in said medium.

7. The extract according to claim 5 , wherein step (a) is preceded by a step of submitting a plant to a conditioning parameter selected from light, osmotic stress, heat, cold, freezing, dryness, hormones, chemical and biological inducers.

8. The extract according to claim 1 , wherein step (a) is preceded by a step of conditioning said organism in a light environment of a wavelength comprised between about 500 and 600 nm, and step (b) is performed under the same light conditions.

9. The extract according to claim 1 , wherein the medium comprises sorbitol in a concentration of about 0.2 to 1.5 M.

10. The extract according to claim 1 , wherein the medium comprises sorbitol in a concentration of about 0.2 to 0.4 M.

11. The extract according to claim 1 , wherein said medium comprises a buffer selected from a Tris buffer, an acetate buffer and an ascorbate buffer.

12. The extract according to claim 1 , wherein said medium comprises about 20 mM Tris or acetate or ascorbate buffer having a pH of 7.5 and about 350 mM sorbitol or sucrose or fructose.

13. The extract according to claim 1 , wherein the separation is based on a difference of sedimentation coefficient of each of the thylakoids, the cell debris/membranes, and the liquid phase.

14. The extract according to claim 13 , wherein the separation comprises centrifugation in a tube equipped with a filter in a superior portion of the tube, the filter having a porosity onto which the cell debris/membranes deposit while the thylakoids and the liquid phase pass through the filter, the thylakoids forming a pellet in an inferior portion of the tube.

15. The extract according to claim 1 , wherein water is eliminated by exchanging it against an amphoteric solvent or surfactant after step (c).

16. The extract according to claim 15 , wherein water is eliminated by exchanging it against propylene glycol.

17. The extract according to claim 1 that is in a state selected from a dry state, a partly or totally solubilized state, and a suspension.

18. A composition comprising the extract according to claim 1 .

Assignments (9)
SECURITY INTEREST Recorded Feb 23, 2024
From: DEVONIAN HEALTH GROUP INC.
To: FIERA PRIVATE DEBT INC.
Reel/Frame 066539/0690 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2024
From: GRX HEALTHCARE INC.
To: GROUPE SANTÉ DEVONIAN INC.
Reel/Frame 066287/0652 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REVERSING ASSIGNOR AND ASSIGNEE INFORMATION PREVIOUSLY RECORDED AT REEL: 49895 FRAME: 301. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 30, 2021
From: INVESTISSEMENT QUÉBEC
To: GROUPE SANTÉ DEVONIAN INC.
Reel/Frame 057688/0869 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 16154364 PREVIOUSLY RECORDED AT REEL: 048359 FRAME: 0174. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 28, 2021
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 057292/0433 →
RELEASE OF SECURITY INTEREST Recorded Jul 29, 2019
From: GROUPE SANTÉ DEVONIAN INC.
To: INVESTISSEMENT QUÉBEC
Reel/Frame 049895/0301 →
SECURITY INTEREST Recorded Feb 18, 2019
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 048359/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2015
From: PURGENESIS TECHNOLOGIES INC.
To: GROUPE SANTÉ DEVONIAN
Reel/Frame 035424/0029 →
SECURITY INTEREST Recorded Jul 9, 2014
From: PURGENESIS TECHNOLOGIES INC.
To: INVESTISSEMENT QUÉBEC
Reel/Frame 033283/0228 →
CHANGE OF NAME Recorded Sep 17, 2009
From: PURECELL TECHNOLOGIES INC.
To: PURGENESIS TECHNOLOGIES INC.
Reel/Frame 023247/0275 →